Do you want to read an article? Please log in or register.
Comparative effectiveness of teriflunomide and dimethyl fumarate: A nationwide cohort study
Multiple Sclerosis
RECOMMENDED
Related content
Multiple Sclerosis
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
J Neurol Neurosurg Psychiatry.
Kalincik T, Kubala Havrdova E, Horakova D, Izquierdo G, Prat A, Girard M, Duquette P, Grammond P, Onofrj M, Lugaresi A, Ozakbas S, Kappos L, Kuhle J, Terzi M, Lechner-Scott J, Boz C, Grand'Maison F, Prevost J, Sola P, Ferraro D, Granella F, Trojano M, Bergamaschi R, Pucci E, Turkoglu R, McCombe PA, Pesch VV, Van Wijmeersch B, Solaro C, Ramo-Tello C, Slee M, Alroughani R, Yamout B, Shaygannejad V, Spitaleri D, Sánchez-Menoyo JL, Ampapa R, Hodgkinson S, Karabudak R, Butler E, Vucic S, Jokubaitis V, Spelman T, Butzkueven H
doi: 10.1136/jnnp-2018-319831.
Multiple Sclerosis
Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies
Eur J Neurol.
Havrdova E, Giovannoni G, Gold R, Fox RJ, Kappos L, Phillips JT, Okwuokenye M, Marantz JL
doi: 10.1111/ene.13272.
Multiple Sclerosis
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study
Neurology.
Prosperini L, Lucchini M, Haggiag S, Bellantonio P, Bianco A, Buscarinu MC, Buttari F, Centonze D, Cortese A, De Giglio L, Fantozzi R, Ferraro E, Fornasiero A, Francia A, Galgani S, Gasperini C, Marfia GA, Millefiorini E, Nociti V, Pontecorvo S, Pozzilli C, Ruggieri S, Salvetti M, Sgarlata E, Mirabella M
doi: 10.1212/WNL.
RECOMMENDED
Multiple Sclerosis
Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Neurol Neuroimmunol Neuroinflamm.
Diem L, Daponte A, Findling O, Miclea A, Briner M, Salmen A, Gold R, Kilidireas C, Chan A, Evangelopoulos ME, Hoepner R
doi: 10.1212/NXI.0000000000000660.
Anxiety and DepressionBipolar DisorderPsychosis and Schizophrenia
Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study
Lancet Psychiatry.
Tiihonen J, Tanskanen A, Hoti F, Vattulainen P, Taipale H, Mehtälä J, Lähteenvuo M
doi: 10.1016/
Psychosis and Schizophrenia
Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
JAMA Psychiatry.
Tiihonen J, Mittendorfer-Rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H
doi: 10.1001/jamapsychiatry.
Multiple Sclerosis
Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis
J Autoimmun.
Diebold M, Sievers C, Bantug G, Sanderson N, Kappos L, Kuhle J, Lindberg RLP, Derfuss T
doi: 10.1016/j.jaut.2017.09.009.
Psychosis and Schizophrenia
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies
Lancet Psychiatry
Kishimoto T, Hagi K, Kurokawa S, Kane JM, Correll CU
doi: 10.1016/S2215-0366(21)00039-0
RECOMMENDED
Multiple Sclerosis
Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice
Neurology.
Mehta D, Miller C, Arnold DL, Bame E, Bar-Or A, Gold R, Hanna J, Kappos L, Liu S, Matta A, Phillips JT, Robertson D, von Hehn CA, Campbell J, Spach K, Yang L, Fox RJ
doi: 10.1212/WNL.